Join’s Substack

Join’s Substack

Home
Notes
Archive
About
China Enters the Longevity Race: Meet the XPRIZE Semifinalist Prometheus Team
They call themselves the Prometheus Cell Team and they aim to reprogram our cells for a 150-year healthspan and their work could mark the beginning of…
 • 
Join Longevity
, 
Peter H. Mathiesen
, and 
Alva Luis
A Cellular Battery Swap to Supercharge Cancer Therapy and Rejuvenate Aging
New research reveals that transplanting healthy mitochondria can disarm aggressive tumors and re-energize the immune system.
 • 
Join Longevity
, 
Peter H. Mathiesen
, and 
Alva Luis
A New Longevity Roadmap : Scientists Define 100 Critical Questions to Solve Aging
A landmark project has created a new guide for aging research, revealing where the field is focused and, more importantly, where the biggest…
 • 
Join Longevity
, 
Peter H. Mathiesen
, and 
Alva Luis

July 2025

When Headlines Miss the Science: Inside Unity’s Senolytic Breakthrough
An insider's perspective reveals that while one of Unity’s Phase 2 trials missed its primary endpoint, their senolytic drug, UBX-1325, demonstrated…
 • 
Join Longevity
, 
Alva Luis
, 
Peter H. Mathiesen
, and 
Mirza Nafeul Islam
Gero’s Chugai Deal: Aging Biology Moves Into the Pharma Mainstream
AI drug-discovery company Gero has signed a licensing deal with Roche-owned Chugai. In a crowded field of AI startups, it was Gero’s commitment to aging…
 • 
Join Longevity
, 
Alva Luis
, 
Peter H. Mathiesen
, and 
Mirza Nafeul Islam
Psilocybin-Telomere Hypothesis: Can Psychedelics Slow Aging?
Psilocybin might act as a geroprotective compound by preserving telomeres
 • 
Join Longevity
, 
Peter H. Mathiesen
, 
Mirza Nafeul Islam
, and 
Alva Luis
Circulate Health raised $12M in Seed Funding led by Khosla Ventures
A longevity startup called Circulate Health is offering therapeutic plasma exchange as a potential anti-aging procedure and it’s collecting data from…
 • 
Join Longevity

June 2025

Cell Therapies Are Finally Delivering Cures
The Promise Delivered: How Cell Therapies Moved From Longevity Hype to Real-World Impact.
 • 
Join Longevity
, 
Alva Luis
, 
Peter H. Mathiesen
, and 
Mirza Nafeul Islam
A New Clinical Trial Just Proved Plasma Exchange Reverses Biological Age
Scientists at the Buck Institute have provided the strongest evidence yet for a true anti-aging therapy, in a placebo-controlled study
 • 
Join Longevity
, 
Alva Luis
, 
Peter H. Mathiesen
, and 
Mirza Nafeul Islam
Tired of Epigenetic Clocks? Finally, a Test Measuring Function, Not Just Biological Age
From Buck Institute and XPRIZE: a breakthrough approach to predict how long you’ll stay active, independent, and able to enjoy life.
 • 
Join Longevity
, 
Alva Luis
, 
Peter H. Mathiesen
, and 
Mirza Nafeul Islam
When Parkinson’s Research Meets Skincare
Beiersdorf and Vincere Biosciences Partner to Bring Mitophagy to Market. This week, a new biotech-skincare alliance is turning heads in the longevity…
 • 
Join Longevity
, 
Alva Luis
, 
Peter H. Mathiesen
, and 
Mirza Nafeul Islam

May 2025

© 2025 Join Longevity
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture